ICD Therapeutics

Founded: 2017 • Age: 9 yrs Acquired By Boehringer Ingelheim
Provider of veterinary healthcare products development marketing services
Request Access
Report Incorrect Data
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About ICD Therapeutics

ICD Therapeutics, established in 2017 and currently in Acquired stage, focuses on providing healthcare solutions, and services to veterinary health. Provider of veterinary healthcare products development marketing services. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.

  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Veterinary & Animal Health → Unlock Sub-Sector → Unlock Segment
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ICD Therapeutics

Premium access

Detailed funding history for ICD Therapeutics

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in ICD Therapeutics

ICD Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Boehringer Ingelheim.

All
Institutional
Investor Description Founded Year Domain Location
Boehringer Ingelheim
Generic drugs and clinical research services are provided globally.
Locked Locked Locked
Premium access

Investor details for ICD Therapeutics

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ICD Therapeutics

Investments
Premium access

Investment portfolio details for ICD Therapeutics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - ICD Therapeutics

Premium access

Detailed financials for ICD Therapeutics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Icd Therapeutics Comparisons

ICD Therapeutics Primary company
Description
Provider of veterinary healthcare products development & mar...
Location
-
Founded Year
2017
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for ICD Therapeutics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ICD Therapeutics

Premium access

Detailed competitors of ICD Therapeutics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Icd Therapeutics

Premium access

Complete news archive for ICD Therapeutics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ICD Therapeutics

ICD Therapeutics was founded in 2017.

ICD Therapeutics, established in 2017 and currently in Acquired stage, focuses on providing healthcare solutions, and services to veterinary health. Provider of veterinary healthcare products development marketing services. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.

ICD Therapeutics has 1 investor. Key investors include Boehringer Ingelheim.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available